Frontlight ResearchEarly access
Trial site
Riga
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis4 trials
- Familial hypercholesterolaemia3 trials
- Coronary artery disease2 trials
- High blood pressure1 trial
- Osteoarthritis1 trial
- Peripheral artery disease1 trial
- Pulmonary arterial hypertension1 trial
- Stroke1 trial
- Phase
- Phase 36 trials
- Phase 1/21 trial
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting5 trials
- Recruiting2 trials
- Completed1 trial
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals9 trials
Running trials
Recruiting
Recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Active, not recruiting
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure1 recruiting
- Multiple sclerosis1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Completed
Terminated
Site data: ClinicalTrials.govUpdated 17 Nov 2026